Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esmerina Tili

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Journal of Nucleic Acids|August 17, 2011
Resveratrol, MicroRNAs, Inflammation, and CancerEsmerina Tili, Jean-Jacques Michaille
Molecules (Basel, Switzerland)|September 23, 2016
Promiscuous Effects of Some Phenolic Natural Products on Inflammation at Least in Part Arise from Their Ability to Modulate the Expression of Global Regulators, Namely microRNAsEsmerina Tili, Jean-Jacques Michaille
Acta Neuropathologica|February 27, 2024
Disruption of the blood-brain barrier is correlated with spike endocytosis by ACE2 + endothelia in the CNS microvasculature in fatal COVID-19. Scientific commentary on "Detection of blood-brain barrier disruption in brains of patients with COVID-19, but no evidence of brain penetration by SARS-CoV-2"Cynthia Magro, Esmerina Tili, Gerard Nuovo
Annals of Diagnostic Pathology|September 16, 2022
The differential immune response in mild versus fatal SARS-CoV2 infectionDavid Suster, Esmerina Tili, Gerard J Nuovo
Signal Transduction and Targeted Therapy|June 16, 2025
Nasopharyngeal carcinoma: a model cancer to understand tumor rejectionGerard J Nuovo, Esmerina Tili, Carlo M Croce
Cancer Letters|January 14, 2018
Friend or Foe: MicroRNAs in the p53 networkZhenghua Luo, Ri Cui, Esmerina Tili, et al.
Pharmacological Reviews|November 25, 2025
miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor responseEsmerina Tili, Jean-Jacques Michaille, Carlo M Croce
International Reviews of Immunology|October 9, 2009
miR-155: on the crosstalk between inflammation and cancerEsmerina Tili, Carlo M Croce, Jean-Jacques Michaille
Immunological Reviews|April 5, 2013
MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancerEsmerina Tili, Jean-Jacques Michaille, Carlo M Croce
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Loss of ICOSL expression in the progression to cervical carcinomaGerard J Nuovo, Esmerina Tili, Carlo M Croce
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Journal of Nucleic Acids|August 17, 2011
Resveratrol, MicroRNAs, Inflammation, and CancerEsmerina Tili, Jean-Jacques Michaille
Molecules (Basel, Switzerland)|September 23, 2016
Promiscuous Effects of Some Phenolic Natural Products on Inflammation at Least in Part Arise from Their Ability to Modulate the Expression of Global Regulators, Namely microRNAsEsmerina Tili, Jean-Jacques Michaille
Acta Neuropathologica|February 27, 2024
Disruption of the blood-brain barrier is correlated with spike endocytosis by ACE2 + endothelia in the CNS microvasculature in fatal COVID-19. Scientific commentary on "Detection of blood-brain barrier disruption in brains of patients with COVID-19, but no evidence of brain penetration by SARS-CoV-2"Cynthia Magro, Esmerina Tili, Gerard Nuovo
Annals of Diagnostic Pathology|September 16, 2022
The differential immune response in mild versus fatal SARS-CoV2 infectionDavid Suster, Esmerina Tili, Gerard J Nuovo
Signal Transduction and Targeted Therapy|June 16, 2025
Nasopharyngeal carcinoma: a model cancer to understand tumor rejectionGerard J Nuovo, Esmerina Tili, Carlo M Croce
Cancer Letters|January 14, 2018
Friend or Foe: MicroRNAs in the p53 networkZhenghua Luo, Ri Cui, Esmerina Tili, et al.
Pharmacological Reviews|November 25, 2025
miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor responseEsmerina Tili, Jean-Jacques Michaille, Carlo M Croce
International Reviews of Immunology|October 9, 2009
miR-155: on the crosstalk between inflammation and cancerEsmerina Tili, Carlo M Croce, Jean-Jacques Michaille
Immunological Reviews|April 5, 2013
MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancerEsmerina Tili, Jean-Jacques Michaille, Carlo M Croce
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2025
Loss of ICOSL expression in the progression to cervical carcinomaGerard J Nuovo, Esmerina Tili, Carlo M Croce
Pageof 7